S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
USPH · US Physical Therapy Inc
NEW YORK STOCK EXCHANGE, INC. - BOATS Real Time Price • USD
US Physical Therapy Inc (USPH)
NEW YORK STOCK EXCHANGE, INC.
Health Care
$86.42
-0.53
(-0.62%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$86.42
$86.31
$87.27
52-WEEK RANGE
$86.42
$58.19
$93.50
What's happening
- USPH is down 0.62% today, trading at $86.42. — Live quote
- Volume today (3,858) is well below its 3-month average of 206,410. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $0.75 actual vs. $0.86 estimated (-12.8%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 6
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (13 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
USPH
+11.44%
vs S&P 500
-1.34%
1-YEAR RETURN
USPH
-2.90%
vs S&P 500
-17.46%
6-MONTH RETURN
USPH
+11.31%
3-MONTH RETURN
USPH
+16.43%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.75
Est. $0.86
MISS -12.8%
2026-04-26 (Q1 2026)
$0.46
Est. $0.56
MISS -17.3%
2026-01-26 (Q4 2025)
$0.67
Est. $0.68
MISS -1.5%
2025-10-26 (Q3 2025)
$0.66
Est. $0.68
MISS -3.4%
Valuation Measures & Ratios
Enterprise Value4$1.39B
Forward P/E525.71
PEG Ratio634.67
Price / Sales (TTM1)1.47
Price / Book72.33
EV4 / Revenue1.71
EV4 / EBITDA14.06
Profit Margin3.97%
Operating Margin9.41%
Return on Equity (ROE8)6.79%
Return on Assets (ROA9)2.64%
Avg Volume (3M)206,410
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $2.71B | — | $2.27B | $1.62B | $866.4M |
| P/E | 66.87 | — | 53.96 | 44.46 | 27.01 |
| Price/Sales | 3.35 | — | 3.04 | 2.26 | 1.28 |
| Price/Book | 6.03 | — | 4.51 | 3.23 | 1.74 |
| EV/Revenue | 3.60 | — | 3.21 | 2.44 | 1.47 |
| EV/EBITDA | 26.73 | — | 22.86 | — | — |
| ROE | 9.02% | — | 8.35% | 7.27% | 6.45% |
| ROA | 3.24% | — | 3.52% | 3.09% | 2.72% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short1,300,274
Change from Prior Settlement+0.52%
% of Float—
Days to Cover (Short Ratio)6.91
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 8.5% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-02; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is 4.0%. Finnhub fundamentals ↗
- Trailing 52-week price return is -2.9%. Finnhub market metrics ↗
- Trailing P/E is 37.0, a high price relative to reported earnings. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on USPH
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $214.1M | $198.3M | $197.1M | $197.3M | $183.8M | $168.0M | $167.2M | $155.7M |
| Gross profit | $41.9M | $32.8M | $36.9M | $41.6M | $31.1M | $29.1M | $33.9M | $28.4M |
| Operating income | $21.9M | $12.5M | $25.3M | $24.9M | $19.6M | $12.8M | $15.6M | $14.9M |
| Net income | $9.9M | $5.0M | $13.1M | $12.4M | $9.9M | $6.6M | $7.5M | $8.0M |
| EPS (diluted) | $0.25 | $-0.12 | $0.48 | $0.58 | $0.80 | $0.39 | $0.47 | $0.46 |
| EPS (basic) | $0.25 | $-0.12 | $0.48 | $0.58 | $0.80 | $0.39 | $0.47 | $0.46 |
| Operating margin | $10 | $6 | $13 | $13 | $11 | $8 | $9 | $10 |
| Net margin | $5 | $3 | $7 | $6 | $5 | $4 | $4 | $5 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.25B | $1.24B | $1.20B | $1.20B | $1.18B | $1.18B | $1.17B | $1.03B |
| Total liabilities | $482.2M | $459.2M | $433.8M | $413.8M | $414.0M | $420.7M | $408.4M | $358.5M |
| Stockholders' equity | $448.7M | $469.0M | $476.4M | $503.6M | $500.8M | $497.3M | $488.9M | $482.8M |
| Total current assets | $139.7M | $139.1M | $140.0M | $138.4M | $140.5M | $145.4M | $137.6M | $204.9M |
| Total current liabilities | $109.9M | $117.3M | $139.0M | $115.1M | $118.8M | $123.8M | $116.3M | $115.3M |
| Cash & equivalents | $24.9M | $28.4M | $35.6M | $31.1M | $34.1M | $39.2M | $41.4M | $117.0M |
| Accounts receivable | $69.6M | $69.1M | $64.2M | $67.6M | $66.0M | $64.8M | $59.0M | $57.0M |
| Other current assets | $16.6M | $13.9M | $16.1M | $16.0M | $13.1M | $15.3M | $10.6M | $10.8M |
| Property, plant & equipment | $40.4M | $38.6M | $35.7M | $34.2M | $32.1M | $32.8M | $32.1M | $26.6M |
| Goodwill | $716.5M | $715.9M | $692.4M | $690.4M | $677.6M | $674.4M | $667.2M | $554.6M |
| Intangible assets | $176.5M | $179.8M | $172.9M | $176.4M | $175.6M | $177.3M | $179.3M | $124.3M |
| Other non-current assets | $6.5M | $7.0M | $6.6M | $4.6M | $4.2M | $4.4M | $5.2M | $2.7M |
| Accrued liabilities | $45.4M | $57.0M | $49.4M | $56.9M | $65.4M | $68.3M | $59.5M | $64.5M |
| Deferred revenue (current) | $753.0K | $1.0M | $737.0K | — | — | — | — | — |
| Short-term debt | $4.6M | $10.8M | $9.9M | $8.8M | $8.2M | $9.3M | $11.0M | $9.6M |
| Other current liabilities | $10.1M | — | $31.6M | — | — | — | — | — |
| Long-term debt | $215.5M | $194.0M | $152.6M | $151.5M | $151.9M | $157.2M | $142.5M | $132.9M |
| Other non-current liabilities | $3.0M | $1.9M | $3.2M | $5.4M | $4.6M | $4.9M | $18.3M | $8.3M |
| Common stock & paid-in capital | $175.0K | $175.0K | $174.0K | $172.0K | $172.0K | $172.0K | $172.0K | $172.0K |
| Retained earnings | $213.4M | $216.9M | $227.2M | $237.3M | $236.4M | $234.2M | $227.3M | $225.9M |
| Accumulated other comprehensive income (loss) | $1.0M | $978.0K | $714.0K | $945.0K | $1.2M | $1.8M | $2.8M | $1.3M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $34.4M | $3.8M | $24.9M | $19.9M | $34.9M | -$4.7M | $19.4M | $22.1M |
| Investing cash flow | -$6.4M | -$39.8M | -$5.4M | -$11.9M | -$12.7M | -$6.6M | -$94.9M | -$5.8M |
| Financing cash flow | -$31.5M | $28.9M | -$15.0M | -$11.0M | -$27.3M | $9.1M | -$153.0K | -$12.2M |
| Depreciation & amortization | $5.9M | $6.0M | $4.6M | $5.8M | $6.1M | $5.9M | $5.7M | $4.4M |
| Share-based compensation | $3.2M | $2.3M | $2.1M | $2.3M | $2.1M | $1.8M | $2.0M | $1.9M |
| Deferred income taxes | $1.9M | $3.3M | -$564.0K | $3.9M | $2.0M | $5.2M | $4.3M | -$165.0K |
| Change in accounts receivable | $3.2M | $5.9M | -$1.6M | $3.4M | $2.9M | $7.3M | -$3.5M | $3.8M |
| Other investing activities | $159.0K | -$324.0K | $167.0K | -$303.0K | -$184.0K | -$44.0K | -$678.0K | $404.0K |
| Share repurchases | $19.2M | — | $5.6M | — | $0 | — | $0 | — |
| Debt issued | $45.6M | — | — | — | $0 | — | $0 | — |
| Debt repaid | $0 | $1.9M | $1.9M | $1.9M | $1.9M | $3.8M | $0 | $1.9M |
| Other financing activities | — | — | — | $7.0K | — | — | $27.0K | -$27.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $781.0M | $671.3M | $604.8M | $553.1M | $495.0M |
| Gross profit | $149.7M | $123.9M | $121.5M | $112.0M | $117.2M |
| Operating income | $86.7M | $63.0M | $50.5M | $56.8M | $70.6M |
| Net income | $39.6M | $31.4M | $28.2M | $32.2M | $40.8M |
| EPS (diluted) | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 |
| EPS (basic) | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 |
| Operating margin | $11 | $9 | $8 | $10 | $14 |
| Net margin | $5 | $5 | $5 | $6 | $8 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jan '22 |
|---|---|---|---|---|---|
| Total assets | $1.20B | $1.17B | $997.2M | $858.2M | — |
| Total liabilities | $433.8M | $408.4M | $345.0M | $373.6M | — |
| Stockholders' equity | $476.4M | $488.9M | $476.2M | $315.8M | — |
| Total current assets | $140.0M | $137.6M | $233.4M | $111.3M | — |
| Total current liabilities | $139.0M | $116.3M | $102.2M | $85.5M | — |
| Cash & equivalents | $35.6M | $41.4M | $152.8M | $31.6M | — |
| Accounts receivable | $64.2M | $59.0M | $51.8M | $51.9M | $46.3M |
| Other current assets | $16.1M | $10.6M | $10.8M | $11.1M | — |
| Property, plant & equipment | $35.7M | $32.1M | $26.1M | $24.7M | — |
| Goodwill | $692.4M | $667.2M | $509.6M | $494.1M | — |
| Intangible assets | $172.9M | $179.3M | $109.7M | $108.8M | — |
| Other non-current assets | $6.6M | $5.2M | $2.8M | $4.1M | — |
| Accrued liabilities | $81.0M | $59.5M | $55.3M | $37.4M | — |
| Short-term debt | $9.9M | $11.0M | $7.7M | $7.9M | — |
| Long-term debt | $152.6M | $142.5M | $139.0M | $175.8M | — |
| Other non-current liabilities | $3.2M | $18.3M | $2.4M | $13.0M | — |
| Common stock & paid-in capital | $174.0K | $172.0K | $172.0K | $152.0K | — |
| Retained earnings | $227.2M | $227.3M | $223.8M | $232.9M | — |
| Accumulated other comprehensive income (loss) | $714.0K | $2.8M | $2.8M | $4.0M | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $75.1M | $74.9M | $82.0M | $58.5M | $76.4M |
| Investing cash flow | -$36.7M | -$149.4M | -$45.0M | -$81.3M | -$124.1M |
| Financing cash flow | -$44.1M | -$37.0M | $84.3M | $25.8M | $43.4M |
| Depreciation & amortization | $22.4M | $18.7M | $15.7M | $14.7M | $11.6M |
| Share-based compensation | $8.3M | $7.8M | $7.2M | $7.3M | $7.9M |
| Deferred income taxes | $10.6M | $4.9M | $4.6M | $12.4M | $5.7M |
| Change in accounts receivable | $12.0M | $5.3M | $5.6M | $10.3M | $9.4M |
| Other investing activities | -$364.0K | -$143.0K | $189.0K | $0 | $0 |
| Share repurchases | $5.6M | $0 | $0 | — | — |
| Debt issued | — | $0 | $0 | $150.0M | $0 |
| Debt repaid | $9.4M | $3.8M | $3.8M | $1.9M | $0 |
| Other financing activities | — | $0 | $0 | $12.0K | $28.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding USPH as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-11-24 to 2026-10-01
Recent transactions
- Insiders have net bought 786 shares over the last 182 days, across 4 purchases and 0 sales.
- Most recent: Davis Myra (Reporting person) — Grant / award of 1,210 shares on 2026-10-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)786 sh(4 txns)
Sales (open market)0 sh(0 txns)
Net Shares+786
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Davis Myra | Reporting person | Grant / award | 2026-10-01 | 1,210 |
| Etta Nchacha | EVP & Chief Financial Officer | Grant / award | 2026-09-14 | 6,831 |
| Minan Peter Francis | Reporting person | Open market purchase | 2026-09-11 | 5 |
| Williams Eric Joseph | President and COO | Tax withholding | 2026-08-20 | 714 |
| CURTIS JASON TRAVIS | Interim CFO | Tax withholding | 2026-08-20 | 40 |
| Binstein Richard | EVP Gen'l Counsel & Secretary | Tax withholding | 2026-08-20 | 450 |
| REEVE GRAHAM D. | COO | Tax withholding | 2026-08-20 | 762 |
| Motsenbocker Anne | Reporting person | Grant / award | 2026-05-19 | 2,306 |
| Swanson Regg E. | Reporting person | Grant / award | 2026-05-19 | 2,306 |
| Harris Bernard A Jr | Reporting person | Grant / award | 2026-05-19 | 2,306 |
| Gilmartin Kathleen A | Reporting person | Grant / award | 2026-05-19 | 2,306 |
| HENDRICKSON CAREY P | Chief Financial Officer | Disposition to issuer | 2026-03-09 | 10,000 |
| READING CHRISTOPHER J | Chairman of the Board and CEO | Grant / award | 2026-02-23 | 25,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | Davis Myra | Reporting person | Grant / award | 1,210 | $0.00 |
| 2026-09-14 | Etta Nchacha | EVP & Chief Financial Officer | Grant / award | 6,831 | $0.00 |
| 2026-09-11 | Minan Peter Francis | Reporting person | Open market purchase | 5 | $79.00 |
| 2026-08-20 | Williams Eric Joseph | President and COO | Tax withholding | 714 | $78.00 |
| 2026-08-20 | CURTIS JASON TRAVIS | Interim CFO | Tax withholding | 40 | $78.00 |
| 2026-08-20 | Binstein Richard | EVP Gen'l Counsel & Secretary | Tax withholding | 450 | $78.00 |
| 2026-08-20 | REEVE GRAHAM D. | COO | Tax withholding | 762 | $78.00 |
| 2026-06-12 | Minan Peter Francis | Reporting person | Open market purchase | 1 | $66.50 |
| 2026-06-09 | Minan Peter Francis | Reporting person | Open market purchase | 288 | $61.50 |
| 2026-06-08 | Minan Peter Francis | Reporting person | Open market purchase | 492 | $63.14 |
| 2026-05-20 | CURTIS JASON TRAVIS | Interim CFO | Tax withholding | 40 | $62.24 |
| 2026-05-20 | REEVE GRAHAM D. | COO | Tax withholding | 762 | $62.24 |
| 2026-05-19 | Motsenbocker Anne | Reporting person | Grant / award | 2,306 | $61.61 |
| 2026-05-19 | Swanson Regg E. | Reporting person | Grant / award | 2,306 | $61.61 |
| 2026-05-19 | Minan Peter Francis | Reporting person | Grant / award | 2,306 | $61.61 |
| 2026-05-19 | Harris Bernard A Jr | Reporting person | Grant / award | 2,306 | $61.61 |
| 2026-05-19 | Gilmartin Kathleen A | Reporting person | Grant / award | 2,306 | $61.61 |
| 2026-03-11 | REEVE GRAHAM D. | COO | Open market sale | 662 | $78.86 |
| 2026-03-09 | REEVE GRAHAM D. | COO | Open market sale | 1 | $78.52 |
| 2026-03-09 | HENDRICKSON CAREY P | Chief Financial Officer | Disposition to issuer | 10,000 | $0.00 |
| 2026-03-06 | REEVE GRAHAM D. | COO | Open market sale | 1,807 | $82.25 |
| 2026-03-06 | Binstein Richard | EVP Gen'l Counsel & Secretary | Open market sale | 3,000 | $81.64 |
| 2026-02-23 | READING CHRISTOPHER J | Chairman of the Board and CEO | Grant / award | 25,000 | $0.00 |
| 2026-02-23 | Williams Eric Joseph | President and COO | Grant / award | 15,000 | $0.00 |
| 2026-02-23 | REEVE GRAHAM D. | COO | Grant / award | 10,000 | $0.00 |
| 2026-02-23 | Binstein Richard | EVP Gen'l Counsel & Secretary | Grant / award | 10,000 | $0.00 |
| 2026-02-23 | HENDRICKSON CAREY P | Chief Financial Officer | Grant / award | 10,000 | $0.00 |
| 2025-11-24 | REEVE GRAHAM D. | COO | Open market sale | 743 | $71.01 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 04:10 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-09-28 | 8-K | 2026-09-22 | View on SEC.gov → |
| 2026-09-21 | 8-K | 2026-09-15 | View on SEC.gov → |
| 2026-09-15 | 4 | 2026-09-14 | View on SEC.gov → |
| 2026-09-14 | 4 | 2026-06-12 | View on SEC.gov → |
| 2026-08-24 | 4 | 2026-08-20 | View on SEC.gov → |
| 2026-08-24 | 4 | 2026-08-20 | View on SEC.gov → |
| 2026-08-24 | 4 | 2026-08-20 | View on SEC.gov → |
| 2026-08-24 | 4 | 2026-08-20 | View on SEC.gov → |
| 2026-08-14 | 8-K | 2026-08-12 | View on SEC.gov → |
| 2026-08-12 | 8-K | 2026-08-12 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-06 | View on SEC.gov → |
Recent news
Headlines about USPH (US Physical Therapy Inc). Links open the publisher — we don’t host full articles.
-
U.S. Physical Therapy, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call Dates
Yahoo · 2026-10-21 -
Copeland Capital Management, LLC Adds US Physical Therapy Inc (U
GuruFocus · 2026-10-15 -
3 Profitable Stocks We Find Risky
Yahoo · 2026-10-13 -
U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
Yahoo Finance · 2026-09-21 -
U.S. Physical Therapy (USPH), What Is Drawing Fresh Attention Now?
Yahoo Finance · 2026-09-21 -
Will a New CFO and Tighter Cash Flow Lens Change U.S. Physical Therapy's (USPH) Narrative
Yahoo Finance · 2026-09-21 -
U.S. Physical Therapy (USPH) Stock Could Be 44% Undervalued After CFO Appointment
Yahoo Finance · 2026-09-20 -
U.S. Physical Therapy Bets on Hospital Alliances to Drive Visits, Reimbursement
Yahoo Finance · 2026-08-27
No headlines in this category right now — try “All”.